HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Fusion Brands new ownership

This article was originally published in The Rose Sheet

Executive Summary

Beauty and fragrance firm Fusion Brands announces retirement of CEO Randi Shinder, who is selling her stake in the company to its majority shareholder, Canadian billionaire Eugene Melnyk, now the sole owner. Fusion Brands says it is in the process of appointing Shinder's successor and will make an announcement soon. "After eight memorable years as founder and CEO of Fusion Brands, Inc., I have decided to sell my remaining equity and take a well deserved break to spend more time with my family," Shinder states May 8. "I will be leaving a great team at Fusion Brands, as well as so many supportive industry colleagues that have been integral to my success." Melnyk acquired a 55% stake in the company in August 2006. He is a founder of specialty pharmaceutical company Biovail Corporation. Fusion Brands makes and markets FusionBeauty skin care and CLEAN perfume

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016160

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel